Quantitative assessment of coronary endothelial function

International Congress Series

Volumn 1264, Issue C, 2004, Pages 132-135

  Morita, Koichi ^a   Katoh, Chietsugu ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular risk factors; Endothelial function; Myocardial blood flow; Vasomotor response

Indexed keywords

EID: 77955616479     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2003.12.045     Document Type: Article

References (25)

1. Nabel, E.G., Biology of the impaired endothelium. Am. J. Cardiol. 68 (1991), 6C–8C.
2. Vallance, P., Chan, N., Endothelial function and nitric oxide: clinical relevance. Heart 85 (2001), 342–350.
3. Zeiher, A.M., et al. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 84 (1991), 1984–1992.
4. Zeiher, A.M., et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83 (1991), 391–401.
5. Gould, K.L., et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation 89 (1994), 1530–1538.
6. Zeiher, A.M., Schachinger, V., Minners, J., Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 92 (1995), 1094–1100.
7. Suwaidi, J.A., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000), 948–954.
8. Schachinger, V., Britten, M.B., Zeiher, A.M., Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:6 (2000), 1890–1899.
9. Halcox, J.P., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002), 653–658.
10. Zeiher, A.M., Drexler, H., Saurbie, B., Just, H., Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J. Clin. Invest. 92 (1993), 652–662.
11. Baller, D., et al. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 99 (1999), 2871–2875.
12. Zeiher, A.M., et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 91 (1995), 2345–2352.
13. Hutchins, G.D., et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J. Am. Coll. Cardiol. 15 (1990), 1032–1042.
14. Uren, N.G., et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N. Engl. J. Med. 330 (1994), 1782–1788.
15. Camici, P.G., et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur. Heart J. 17 (1996), 25–34.
16. Kaufmann, P.A., et al. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J. Nucl. Med. 40 (1999), 1848–1856.
17. Beanlands, R.S., et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J. Am. Coll. Cardiol. 26 (1995), 1465–1475.
18. Corretti, M.C., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39 (2002), 257–265.
19. Bottcher, M., et al. Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve. Circulation 103 (2001), 1109–1114.
20. Zeiher, A.M., et al. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J. Am. Coll. Cardiol. 14 (1989), 1181–1190.
21. Campisi, R., et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 98 (1998), 119–125.
22. Campisi, R., et al. L-Arginine normalizes coronary vasomotion in long-term smokers. Circulation, 1999, 491–497.
23. Iwado, Y., et al. Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Eur. J. Nucl. Med. Mol. Imaging 29 (2002), 984–990.
24. Kaufmann, P.A., et al. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 102 (2000), 1233–1238.
25. Schindler, T.H., et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J. Am. Coll. Cardiol. 42 (2003), 814–822.